nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0457	0.121	CbGbCtD
Sunitinib—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0413	0.109	CbGbCtD
Sunitinib—ABCC4—Methotrexate—ankylosing spondylitis	0.0308	0.0813	CbGbCtD
Sunitinib—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0229	0.0604	CbGbCtD
Sunitinib—ABCC2—Dexamethasone—ankylosing spondylitis	0.0228	0.0602	CbGbCtD
Sunitinib—ABCG2—Dexamethasone—ankylosing spondylitis	0.0206	0.0544	CbGbCtD
Sunitinib—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0197	0.0519	CbGbCtD
Sunitinib—ABCC2—Methotrexate—ankylosing spondylitis	0.0183	0.0484	CbGbCtD
Sunitinib—ABCG2—Methotrexate—ankylosing spondylitis	0.0166	0.0437	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0152	0.0402	CbGbCtD
Sunitinib—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0152	0.0402	CbGbCtD
Sunitinib—ABCB1—Betamethasone—ankylosing spondylitis	0.0128	0.0337	CbGbCtD
Sunitinib—ABCB1—Prednisolone—ankylosing spondylitis	0.0126	0.0333	CbGbCtD
Sunitinib—ABCB1—Prednisone—ankylosing spondylitis	0.0119	0.0314	CbGbCtD
Sunitinib—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0118	0.0311	CbGbCtD
Sunitinib—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0114	0.0302	CbGbCtD
Sunitinib—PKN1—synovial membrane of synovial joint—ankylosing spondylitis	0.0099	0.0753	CbGeAlD
Sunitinib—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00892	0.0236	CbGbCtD
Sunitinib—CYP3A4—Betamethasone—ankylosing spondylitis	0.00766	0.0202	CbGbCtD
Sunitinib—CYP3A4—Prednisolone—ankylosing spondylitis	0.00755	0.0199	CbGbCtD
Sunitinib—ABCB1—Dexamethasone—ankylosing spondylitis	0.00743	0.0196	CbGbCtD
Sunitinib—CYP3A4—Prednisone—ankylosing spondylitis	0.00713	0.0188	CbGbCtD
Sunitinib—BMP2K—synovial membrane of synovial joint—ankylosing spondylitis	0.00687	0.0523	CbGeAlD
Sunitinib—ABCB1—Methotrexate—ankylosing spondylitis	0.00597	0.0158	CbGbCtD
Sunitinib—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00445	0.0118	CbGbCtD
Sunitinib—MYLK2—tendon—ankylosing spondylitis	0.00421	0.032	CbGeAlD
Sunitinib—HUNK—tendon—ankylosing spondylitis	0.00319	0.0243	CbGeAlD
Sunitinib—MYLK4—tendon—ankylosing spondylitis	0.00271	0.0206	CbGeAlD
Sunitinib—MYLK3—tendon—ankylosing spondylitis	0.00263	0.02	CbGeAlD
Sunitinib—NIM1K—tendon—ankylosing spondylitis	0.00231	0.0175	CbGeAlD
Sunitinib—PRKAA2—tendon—ankylosing spondylitis	0.00221	0.0168	CbGeAlD
Sunitinib—STK17B—tendon—ankylosing spondylitis	0.00213	0.0162	CbGeAlD
Sunitinib—STK17A—tendon—ankylosing spondylitis	0.00196	0.0149	CbGeAlD
Sunitinib—CDK14—tendon—ankylosing spondylitis	0.00193	0.0147	CbGeAlD
Sunitinib—LATS2—tendon—ankylosing spondylitis	0.00191	0.0145	CbGeAlD
Sunitinib—CLK4—tendon—ankylosing spondylitis	0.00181	0.0138	CbGeAlD
Sunitinib—SBK1—tendon—ankylosing spondylitis	0.00179	0.0136	CbGeAlD
Sunitinib—DAPK1—tendon—ankylosing spondylitis	0.00175	0.0133	CbGeAlD
Sunitinib—PHKG1—tendon—ankylosing spondylitis	0.00175	0.0133	CbGeAlD
Sunitinib—RIOK1—tendon—ankylosing spondylitis	0.00168	0.0127	CbGeAlD
Sunitinib—RPS6KA1—tendon—ankylosing spondylitis	0.00168	0.0127	CbGeAlD
Sunitinib—MARK2—tendon—ankylosing spondylitis	0.00164	0.0125	CbGeAlD
Sunitinib—TNIK—tendon—ankylosing spondylitis	0.00164	0.0125	CbGeAlD
Sunitinib—SGK3—tendon—ankylosing spondylitis	0.00163	0.0124	CbGeAlD
Sunitinib—ICK—tendon—ankylosing spondylitis	0.00161	0.0123	CbGeAlD
Sunitinib—CHEK2—tendon—ankylosing spondylitis	0.00156	0.0119	CbGeAlD
Sunitinib—NUAK1—tendon—ankylosing spondylitis	0.00156	0.0119	CbGeAlD
Sunitinib—INSR—tendon—ankylosing spondylitis	0.00155	0.0118	CbGeAlD
Sunitinib—OXSR1—tendon—ankylosing spondylitis	0.00155	0.0118	CbGeAlD
Sunitinib—SNRK—tendon—ankylosing spondylitis	0.00155	0.0118	CbGeAlD
Sunitinib—RPS6KA2—tendon—ankylosing spondylitis	0.00152	0.0116	CbGeAlD
Sunitinib—STK38—tendon—ankylosing spondylitis	0.00152	0.0116	CbGeAlD
Sunitinib—AURKC—tendon—ankylosing spondylitis	0.00151	0.0115	CbGeAlD
Sunitinib—CSNK1G2—tendon—ankylosing spondylitis	0.0015	0.0114	CbGeAlD
Sunitinib—PKN1—tendon—ankylosing spondylitis	0.0015	0.0114	CbGeAlD
Sunitinib—TLK2—Progesterone—Prednisolone—ankylosing spondylitis	0.0015	0.276	CbGdCrCtD
Sunitinib—PRPF4—tendon—ankylosing spondylitis	0.00148	0.0112	CbGeAlD
Sunitinib—PRPF4B—tendon—ankylosing spondylitis	0.00145	0.0111	CbGeAlD
Sunitinib—STK39—tendon—ankylosing spondylitis	0.00143	0.0109	CbGeAlD
Sunitinib—CSNK2A1—tendon—ankylosing spondylitis	0.00142	0.0108	CbGeAlD
Sunitinib—PHKG2—tendon—ankylosing spondylitis	0.00135	0.0103	CbGeAlD
Sunitinib—STK24—tendon—ankylosing spondylitis	0.00134	0.0102	CbGeAlD
Sunitinib—DAPK2—tendon—ankylosing spondylitis	0.00132	0.0101	CbGeAlD
Sunitinib—STK16—tendon—ankylosing spondylitis	0.0013	0.00991	CbGeAlD
Sunitinib—HIPK2—tendon—ankylosing spondylitis	0.0013	0.00986	CbGeAlD
Sunitinib—HIPK3—tendon—ankylosing spondylitis	0.0013	0.00986	CbGeAlD
Sunitinib—RIOK2—tendon—ankylosing spondylitis	0.00128	0.00976	CbGeAlD
Sunitinib—TNK1—tendon—ankylosing spondylitis	0.00128	0.00976	CbGeAlD
Sunitinib—MAP4K1—tendon—ankylosing spondylitis	0.00127	0.00966	CbGeAlD
Sunitinib—DAPK3—tendon—ankylosing spondylitis	0.00125	0.00948	CbGeAlD
Sunitinib—CLK2—tendon—ankylosing spondylitis	0.00123	0.00939	CbGeAlD
Sunitinib—MAP4K2—tendon—ankylosing spondylitis	0.00123	0.00934	CbGeAlD
Sunitinib—STK3—tendon—ankylosing spondylitis	0.00121	0.00922	CbGeAlD
Sunitinib—MERTK—tendon—ankylosing spondylitis	0.00114	0.00867	CbGeAlD
Sunitinib—MAP4K4—tendon—ankylosing spondylitis	0.00112	0.00851	CbGeAlD
Sunitinib—MAP3K12—tendon—ankylosing spondylitis	0.0011	0.00839	CbGeAlD
Sunitinib—RPS6KA3—tendon—ankylosing spondylitis	0.00109	0.00827	CbGeAlD
Sunitinib—CSNK1A1—tendon—ankylosing spondylitis	0.00107	0.00811	CbGeAlD
Sunitinib—CLK1—tendon—ankylosing spondylitis	0.00106	0.00806	CbGeAlD
Sunitinib—CAMK2G—tendon—ankylosing spondylitis	0.00104	0.00791	CbGeAlD
Sunitinib—BMP2K—tendon—ankylosing spondylitis	0.00104	0.00791	CbGeAlD
Sunitinib—LRRK2—tendon—ankylosing spondylitis	0.00103	0.00784	CbGeAlD
Sunitinib—PTK2B—tendon—ankylosing spondylitis	0.001	0.00764	CbGeAlD
Sunitinib—CSNK1E—tendon—ankylosing spondylitis	0.000988	0.00751	CbGeAlD
Sunitinib—FGFR1—tendon—ankylosing spondylitis	0.000988	0.00751	CbGeAlD
Sunitinib—IRAK4—tendon—ankylosing spondylitis	0.000972	0.0074	CbGeAlD
Sunitinib—MAP2K2—tendon—ankylosing spondylitis	0.000951	0.00723	CbGeAlD
Sunitinib—ULK3—tendon—ankylosing spondylitis	0.000951	0.00723	CbGeAlD
Sunitinib—MAP3K7—tendon—ankylosing spondylitis	0.000935	0.00711	CbGeAlD
Sunitinib—TBK1—tendon—ankylosing spondylitis	0.000924	0.00703	CbGeAlD
Sunitinib—TYK2—tendon—ankylosing spondylitis	0.000918	0.00699	CbGeAlD
Sunitinib—IRAK1—tendon—ankylosing spondylitis	0.000906	0.00689	CbGeAlD
Sunitinib—RPS6KB1—tendon—ankylosing spondylitis	0.000889	0.00677	CbGeAlD
Sunitinib—FGR—tendon—ankylosing spondylitis	0.000884	0.00672	CbGeAlD
Sunitinib—RET—tendon—ankylosing spondylitis	0.000884	0.00672	CbGeAlD
Sunitinib—AXL—tendon—ankylosing spondylitis	0.00088	0.0067	CbGeAlD
Sunitinib—SLK—tendon—ankylosing spondylitis	0.000847	0.00645	CbGeAlD
Sunitinib—JAK2—tendon—ankylosing spondylitis	0.000835	0.00636	CbGeAlD
Sunitinib—FYN—tendon—ankylosing spondylitis	0.000824	0.00627	CbGeAlD
Sunitinib—MAP4K5—tendon—ankylosing spondylitis	0.000805	0.00613	CbGeAlD
Sunitinib—MAP3K3—tendon—ankylosing spondylitis	0.000805	0.00613	CbGeAlD
Sunitinib—FLT1—tendon—ankylosing spondylitis	0.000778	0.00592	CbGeAlD
Sunitinib—EPHB6—tendon—ankylosing spondylitis	0.000769	0.00585	CbGeAlD
Sunitinib—YES1—tendon—ankylosing spondylitis	0.000744	0.00566	CbGeAlD
Sunitinib—STK10—tendon—ankylosing spondylitis	0.000737	0.00561	CbGeAlD
Sunitinib—TAOK3—tendon—ankylosing spondylitis	0.000734	0.00558	CbGeAlD
Sunitinib—PDGFRA—tendon—ankylosing spondylitis	0.000729	0.00555	CbGeAlD
Sunitinib—KDR—tendon—ankylosing spondylitis	0.000658	0.00501	CbGeAlD
Sunitinib—MAP2K5—tendon—ankylosing spondylitis	0.000658	0.00501	CbGeAlD
Sunitinib—CSF1R—tendon—ankylosing spondylitis	0.000642	0.00489	CbGeAlD
Sunitinib—PDGFRB—tendon—ankylosing spondylitis	0.00057	0.00433	CbGeAlD
Sunitinib—CSNK1E—Danazol—Prednisone—ankylosing spondylitis	0.000482	0.0888	CbGdCrCtD
Sunitinib—ABCC4—tendon—ankylosing spondylitis	0.000453	0.00345	CbGeAlD
Sunitinib—ABCC2—tendon—ankylosing spondylitis	0.000439	0.00334	CbGeAlD
Sunitinib—CSNK1E—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000337	0.0621	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000337	0.0621	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000332	0.0611	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000332	0.0611	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000324	0.0597	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000324	0.0597	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisone—ankylosing spondylitis	0.000307	0.0567	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Prednisone—ankylosing spondylitis	0.000307	0.0567	CbGdCrCtD
Sunitinib—CSNK1E—Betamethasone—Prednisolone—ankylosing spondylitis	0.0003	0.0553	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisolone—ankylosing spondylitis	0.0003	0.0553	CbGdCrCtD
Sunitinib—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000256	0.00117	CcSEcCtD
Sunitinib—Eye disorder—Betamethasone—ankylosing spondylitis	0.000256	0.00117	CcSEcCtD
Sunitinib—Back pain—Triamcinolone—ankylosing spondylitis	0.000254	0.00116	CcSEcCtD
Sunitinib—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000248	0.00113	CcSEcCtD
Sunitinib—Angiopathy—Betamethasone—ankylosing spondylitis	0.000248	0.00113	CcSEcCtD
Sunitinib—Convulsion—Prednisolone—ankylosing spondylitis	0.000247	0.00113	CcSEcCtD
Sunitinib—CHEK2—Danazol—Prednisone—ankylosing spondylitis	0.000247	0.0454	CbGdCrCtD
Sunitinib—Hypertension—Prednisolone—ankylosing spondylitis	0.000246	0.00113	CcSEcCtD
Sunitinib—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000244	0.00112	CcSEcCtD
Sunitinib—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000244	0.00112	CcSEcCtD
Sunitinib—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000244	0.00111	CcSEcCtD
Sunitinib—Bradycardia—Prednisone—ankylosing spondylitis	0.000242	0.00111	CcSEcCtD
Sunitinib—Alopecia—Dexamethasone—ankylosing spondylitis	0.000242	0.0011	CcSEcCtD
Sunitinib—Alopecia—Betamethasone—ankylosing spondylitis	0.000242	0.0011	CcSEcCtD
Sunitinib—Angioedema—Triamcinolone—ankylosing spondylitis	0.00024	0.0011	CcSEcCtD
Sunitinib—Haemoglobin—Prednisone—ankylosing spondylitis	0.000239	0.00109	CcSEcCtD
Sunitinib—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000239	0.00109	CcSEcCtD
Sunitinib—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.000238	0.00109	CcSEcCtD
Sunitinib—Haemorrhage—Prednisone—ankylosing spondylitis	0.000238	0.00109	CcSEcCtD
Sunitinib—Erythema—Dexamethasone—ankylosing spondylitis	0.000238	0.00109	CcSEcCtD
Sunitinib—Erythema—Betamethasone—ankylosing spondylitis	0.000238	0.00109	CcSEcCtD
Sunitinib—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000236	0.00108	CcSEcCtD
Sunitinib—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000234	0.00107	CcSEcCtD
Sunitinib—Oedema—Prednisolone—ankylosing spondylitis	0.000233	0.00106	CcSEcCtD
Sunitinib—Neutropenia—Methotrexate—ankylosing spondylitis	0.000233	0.00106	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000231	0.00106	CcSEcCtD
Sunitinib—Shock—Prednisolone—ankylosing spondylitis	0.000229	0.00105	CcSEcCtD
Sunitinib—Cough—Triamcinolone—ankylosing spondylitis	0.000229	0.00105	CcSEcCtD
Sunitinib—Convulsion—Triamcinolone—ankylosing spondylitis	0.000227	0.00104	CcSEcCtD
Sunitinib—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000227	0.00104	CcSEcCtD
Sunitinib—Hypertension—Triamcinolone—ankylosing spondylitis	0.000227	0.00104	CcSEcCtD
Sunitinib—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000226	0.00103	CcSEcCtD
Sunitinib—Myalgia—Triamcinolone—ankylosing spondylitis	0.000223	0.00102	CcSEcCtD
Sunitinib—Pneumonia—Methotrexate—ankylosing spondylitis	0.000223	0.00102	CcSEcCtD
Sunitinib—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000223	0.00102	CcSEcCtD
Sunitinib—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000223	0.00102	CcSEcCtD
Sunitinib—Eye disorder—Prednisone—ankylosing spondylitis	0.000223	0.00102	CcSEcCtD
Sunitinib—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000222	0.00101	CcSEcCtD
Sunitinib—Infestation—Methotrexate—ankylosing spondylitis	0.000222	0.00101	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000221	0.00101	CcSEcCtD
Sunitinib—Depression—Methotrexate—ankylosing spondylitis	0.000221	0.00101	CcSEcCtD
Sunitinib—Flushing—Prednisone—ankylosing spondylitis	0.000221	0.00101	CcSEcCtD
Sunitinib—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00022	0.001	CcSEcCtD
Sunitinib—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000218	0.000998	CcSEcCtD
Sunitinib—Renal failure—Methotrexate—ankylosing spondylitis	0.000218	0.000996	CcSEcCtD
Sunitinib—Angioedema—Betamethasone—ankylosing spondylitis	0.000218	0.000994	CcSEcCtD
Sunitinib—Angioedema—Dexamethasone—ankylosing spondylitis	0.000218	0.000994	CcSEcCtD
Sunitinib—Stomatitis—Methotrexate—ankylosing spondylitis	0.000216	0.000988	CcSEcCtD
Sunitinib—Angiopathy—Prednisone—ankylosing spondylitis	0.000216	0.000988	CcSEcCtD
Sunitinib—Immune system disorder—Prednisone—ankylosing spondylitis	0.000215	0.000983	CcSEcCtD
Sunitinib—Oedema—Triamcinolone—ankylosing spondylitis	0.000214	0.000979	CcSEcCtD
Sunitinib—Arrhythmia—Prednisone—ankylosing spondylitis	0.000213	0.000972	CcSEcCtD
Sunitinib—Infection—Triamcinolone—ankylosing spondylitis	0.000213	0.000972	CcSEcCtD
Sunitinib—Infection—Methylprednisolone—ankylosing spondylitis	0.000212	0.00097	CcSEcCtD
Sunitinib—Shock—Triamcinolone—ankylosing spondylitis	0.000211	0.000963	CcSEcCtD
Sunitinib—Insomnia—Prednisolone—ankylosing spondylitis	0.000211	0.000963	CcSEcCtD
Sunitinib—Alopecia—Prednisone—ankylosing spondylitis	0.00021	0.000962	CcSEcCtD
Sunitinib—Shock—Methylprednisolone—ankylosing spondylitis	0.00021	0.000961	CcSEcCtD
Sunitinib—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00021	0.000958	CcSEcCtD
Sunitinib—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00021	0.000958	CcSEcCtD
Sunitinib—Epistaxis—Methotrexate—ankylosing spondylitis	0.000209	0.000956	CcSEcCtD
Sunitinib—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000209	0.000956	CcSEcCtD
Sunitinib—Mental disorder—Prednisone—ankylosing spondylitis	0.000209	0.000954	CcSEcCtD
Sunitinib—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000208	0.000949	CcSEcCtD
Sunitinib—Erythema—Prednisone—ankylosing spondylitis	0.000207	0.000948	CcSEcCtD
Sunitinib—Malnutrition—Prednisone—ankylosing spondylitis	0.000207	0.000948	CcSEcCtD
Sunitinib—Convulsion—Betamethasone—ankylosing spondylitis	0.000206	0.000943	CcSEcCtD
Sunitinib—Convulsion—Dexamethasone—ankylosing spondylitis	0.000206	0.000943	CcSEcCtD
Sunitinib—Hypertension—Dexamethasone—ankylosing spondylitis	0.000206	0.000939	CcSEcCtD
Sunitinib—Hypertension—Betamethasone—ankylosing spondylitis	0.000206	0.000939	CcSEcCtD
Sunitinib—Myalgia—Dexamethasone—ankylosing spondylitis	0.000203	0.000926	CcSEcCtD
Sunitinib—Myalgia—Betamethasone—ankylosing spondylitis	0.000203	0.000926	CcSEcCtD
Sunitinib—Haemoglobin—Methotrexate—ankylosing spondylitis	0.0002	0.000914	CcSEcCtD
Sunitinib—Pain—Prednisolone—ankylosing spondylitis	0.000199	0.00091	CcSEcCtD
Sunitinib—Hepatitis—Methotrexate—ankylosing spondylitis	0.000199	0.00091	CcSEcCtD
Sunitinib—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000199	0.00091	CcSEcCtD
Sunitinib—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000197	0.000898	CcSEcCtD
Sunitinib—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000195	0.000892	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000195	0.000892	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000195	0.00089	CcSEcCtD
Sunitinib—Oedema—Betamethasone—ankylosing spondylitis	0.000194	0.000888	CcSEcCtD
Sunitinib—Oedema—Dexamethasone—ankylosing spondylitis	0.000194	0.000888	CcSEcCtD
Sunitinib—Insomnia—Triamcinolone—ankylosing spondylitis	0.000194	0.000885	CcSEcCtD
Sunitinib—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000193	0.000883	CcSEcCtD
Sunitinib—Infection—Dexamethasone—ankylosing spondylitis	0.000193	0.000882	CcSEcCtD
Sunitinib—Infection—Betamethasone—ankylosing spondylitis	0.000193	0.000882	CcSEcCtD
Sunitinib—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000192	0.000879	CcSEcCtD
Sunitinib—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000192	0.000877	CcSEcCtD
Sunitinib—Anaemia—Prednisone—ankylosing spondylitis	0.000192	0.000876	CcSEcCtD
Sunitinib—Shock—Betamethasone—ankylosing spondylitis	0.000191	0.000874	CcSEcCtD
Sunitinib—Shock—Dexamethasone—ankylosing spondylitis	0.000191	0.000874	CcSEcCtD
Sunitinib—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000191	0.000873	CcSEcCtD
Sunitinib—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000191	0.000871	CcSEcCtD
Sunitinib—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000191	0.000871	CcSEcCtD
Sunitinib—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00019	0.000869	CcSEcCtD
Sunitinib—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00019	0.000869	CcSEcCtD
Sunitinib—Angioedema—Prednisone—ankylosing spondylitis	0.000189	0.000866	CcSEcCtD
Sunitinib—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000188	0.000862	CcSEcCtD
Sunitinib—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000188	0.00086	CcSEcCtD
Sunitinib—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000188	0.00086	CcSEcCtD
Sunitinib—Eye disorder—Methotrexate—ankylosing spondylitis	0.000186	0.00085	CcSEcCtD
Sunitinib—Anorexia—Dexamethasone—ankylosing spondylitis	0.000185	0.000846	CcSEcCtD
Sunitinib—Anorexia—Betamethasone—ankylosing spondylitis	0.000185	0.000846	CcSEcCtD
Sunitinib—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000185	0.000844	CcSEcCtD
Sunitinib—Fatigue—Triamcinolone—ankylosing spondylitis	0.000185	0.000844	CcSEcCtD
Sunitinib—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000184	0.000842	CcSEcCtD
Sunitinib—Pain—Triamcinolone—ankylosing spondylitis	0.000183	0.000837	CcSEcCtD
Sunitinib—Angiopathy—Methotrexate—ankylosing spondylitis	0.000181	0.000825	CcSEcCtD
Sunitinib—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00018	0.000822	CcSEcCtD
Sunitinib—Convulsion—Prednisone—ankylosing spondylitis	0.00018	0.000821	CcSEcCtD
Sunitinib—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000179	0.00082	CcSEcCtD
Sunitinib—Hypertension—Prednisone—ankylosing spondylitis	0.000179	0.000818	CcSEcCtD
Sunitinib—Chills—Methotrexate—ankylosing spondylitis	0.000179	0.000816	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000177	0.000809	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000177	0.000809	CcSEcCtD
Sunitinib—Myalgia—Prednisone—ankylosing spondylitis	0.000176	0.000807	CcSEcCtD
Sunitinib—Arthralgia—Prednisone—ankylosing spondylitis	0.000176	0.000807	CcSEcCtD
Sunitinib—Alopecia—Methotrexate—ankylosing spondylitis	0.000176	0.000804	CcSEcCtD
Sunitinib—Insomnia—Betamethasone—ankylosing spondylitis	0.000176	0.000803	CcSEcCtD
Sunitinib—Insomnia—Dexamethasone—ankylosing spondylitis	0.000176	0.000803	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000175	0.000801	CcSEcCtD
Sunitinib—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000175	0.000799	CcSEcCtD
Sunitinib—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000174	0.000797	CcSEcCtD
Sunitinib—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000174	0.000797	CcSEcCtD
Sunitinib—Mental disorder—Methotrexate—ankylosing spondylitis	0.000174	0.000797	CcSEcCtD
Sunitinib—Erythema—Methotrexate—ankylosing spondylitis	0.000173	0.000792	CcSEcCtD
Sunitinib—Malnutrition—Methotrexate—ankylosing spondylitis	0.000173	0.000792	CcSEcCtD
Sunitinib—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000172	0.000784	CcSEcCtD
Sunitinib—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000171	0.000782	CcSEcCtD
Sunitinib—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000171	0.000782	CcSEcCtD
Sunitinib—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00017	0.000776	CcSEcCtD
Sunitinib—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000169	0.000774	CcSEcCtD
Sunitinib—Oedema—Prednisone—ankylosing spondylitis	0.000169	0.000773	CcSEcCtD
Sunitinib—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000169	0.000772	CcSEcCtD
Sunitinib—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000169	0.000772	CcSEcCtD
Sunitinib—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000169	0.000772	CcSEcCtD
Sunitinib—Infection—Prednisone—ankylosing spondylitis	0.000168	0.000768	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000168	0.000767	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000168	0.000767	CcSEcCtD
Sunitinib—Back pain—Methotrexate—ankylosing spondylitis	0.000168	0.000766	CcSEcCtD
Sunitinib—Fatigue—Betamethasone—ankylosing spondylitis	0.000167	0.000766	CcSEcCtD
Sunitinib—Fatigue—Dexamethasone—ankylosing spondylitis	0.000167	0.000766	CcSEcCtD
Sunitinib—Shock—Prednisone—ankylosing spondylitis	0.000166	0.000761	CcSEcCtD
Sunitinib—Pain—Betamethasone—ankylosing spondylitis	0.000166	0.000759	CcSEcCtD
Sunitinib—Pain—Dexamethasone—ankylosing spondylitis	0.000166	0.000759	CcSEcCtD
Sunitinib—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000166	0.000758	CcSEcCtD
Sunitinib—Skin disorder—Prednisone—ankylosing spondylitis	0.000164	0.000751	CcSEcCtD
Sunitinib—Anorexia—Prednisone—ankylosing spondylitis	0.000161	0.000737	CcSEcCtD
Sunitinib—Anaemia—Methotrexate—ankylosing spondylitis	0.00016	0.000732	CcSEcCtD
Sunitinib—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000159	0.000726	CcSEcCtD
Sunitinib—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000159	0.000726	CcSEcCtD
Sunitinib—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000158	0.000721	CcSEcCtD
Sunitinib—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000157	0.000719	CcSEcCtD
Sunitinib—Leukopenia—Methotrexate—ankylosing spondylitis	0.000155	0.000709	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000154	0.000705	CcSEcCtD
Sunitinib—Dizziness—Prednisolone—ankylosing spondylitis	0.000154	0.000704	CcSEcCtD
Sunitinib—Asthenia—Triamcinolone—ankylosing spondylitis	0.000154	0.000702	CcSEcCtD
Sunitinib—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000154	0.000702	CcSEcCtD
Sunitinib—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000154	0.000702	CcSEcCtD
Sunitinib—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000154	0.000702	CcSEcCtD
Sunitinib—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000154	0.000702	CcSEcCtD
Sunitinib—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000153	0.000701	CcSEcCtD
Sunitinib—Insomnia—Prednisone—ankylosing spondylitis	0.000153	0.000699	CcSEcCtD
Sunitinib—Paraesthesia—Prednisone—ankylosing spondylitis	0.000152	0.000694	CcSEcCtD
Sunitinib—Pruritus—Triamcinolone—ankylosing spondylitis	0.000151	0.000692	CcSEcCtD
Sunitinib—Cough—Methotrexate—ankylosing spondylitis	0.000151	0.000691	CcSEcCtD
Sunitinib—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000151	0.000691	CcSEcCtD
Sunitinib—Convulsion—Methotrexate—ankylosing spondylitis	0.00015	0.000686	CcSEcCtD
Sunitinib—Dyspepsia—Prednisone—ankylosing spondylitis	0.000149	0.000681	CcSEcCtD
Sunitinib—Myalgia—Methotrexate—ankylosing spondylitis	0.000147	0.000674	CcSEcCtD
Sunitinib—Chest pain—Methotrexate—ankylosing spondylitis	0.000147	0.000674	CcSEcCtD
Sunitinib—Arthralgia—Methotrexate—ankylosing spondylitis	0.000147	0.000674	CcSEcCtD
Sunitinib—Decreased appetite—Prednisone—ankylosing spondylitis	0.000147	0.000672	CcSEcCtD
Sunitinib—Rash—Prednisolone—ankylosing spondylitis	0.000147	0.000671	CcSEcCtD
Sunitinib—Dermatitis—Prednisolone—ankylosing spondylitis	0.000147	0.00067	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000146	0.00067	CcSEcCtD
Sunitinib—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000146	0.000668	CcSEcCtD
Sunitinib—Fatigue—Prednisone—ankylosing spondylitis	0.000146	0.000667	CcSEcCtD
Sunitinib—Headache—Prednisolone—ankylosing spondylitis	0.000146	0.000667	CcSEcCtD
Sunitinib—Constipation—Prednisone—ankylosing spondylitis	0.000145	0.000661	CcSEcCtD
Sunitinib—Dizziness—Triamcinolone—ankylosing spondylitis	0.000142	0.000647	CcSEcCtD
Sunitinib—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000141	0.000646	CcSEcCtD
Sunitinib—Infection—Methotrexate—ankylosing spondylitis	0.00014	0.000642	CcSEcCtD
Sunitinib—Asthenia—Betamethasone—ankylosing spondylitis	0.000139	0.000637	CcSEcCtD
Sunitinib—Asthenia—Dexamethasone—ankylosing spondylitis	0.000139	0.000637	CcSEcCtD
Sunitinib—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000139	0.000634	CcSEcCtD
Sunitinib—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000138	0.000633	CcSEcCtD
Sunitinib—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000138	0.000632	CcSEcCtD
Sunitinib—Nausea—Prednisolone—ankylosing spondylitis	0.000138	0.000632	CcSEcCtD
Sunitinib—Pruritus—Betamethasone—ankylosing spondylitis	0.000137	0.000628	CcSEcCtD
Sunitinib—Pruritus—Dexamethasone—ankylosing spondylitis	0.000137	0.000628	CcSEcCtD
Sunitinib—Skin disorder—Methotrexate—ankylosing spondylitis	0.000137	0.000628	CcSEcCtD
Sunitinib—Vomiting—Triamcinolone—ankylosing spondylitis	0.000136	0.000622	CcSEcCtD
Sunitinib—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000136	0.000621	CcSEcCtD
Sunitinib—Rash—Triamcinolone—ankylosing spondylitis	0.000135	0.000617	CcSEcCtD
Sunitinib—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000135	0.000617	CcSEcCtD
Sunitinib—Anorexia—Methotrexate—ankylosing spondylitis	0.000135	0.000616	CcSEcCtD
Sunitinib—Rash—Methylprednisolone—ankylosing spondylitis	0.000135	0.000616	CcSEcCtD
Sunitinib—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000135	0.000615	CcSEcCtD
Sunitinib—Headache—Triamcinolone—ankylosing spondylitis	0.000134	0.000613	CcSEcCtD
Sunitinib—Headache—Methylprednisolone—ankylosing spondylitis	0.000134	0.000612	CcSEcCtD
Sunitinib—Abdominal pain—Prednisone—ankylosing spondylitis	0.000134	0.000611	CcSEcCtD
Sunitinib—Body temperature increased—Prednisone—ankylosing spondylitis	0.000134	0.000611	CcSEcCtD
Sunitinib—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000133	0.000608	CcSEcCtD
Sunitinib—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000133	0.000608	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000129	0.000589	CcSEcCtD
Sunitinib—Dizziness—Dexamethasone—ankylosing spondylitis	0.000128	0.000587	CcSEcCtD
Sunitinib—Dizziness—Betamethasone—ankylosing spondylitis	0.000128	0.000587	CcSEcCtD
Sunitinib—Insomnia—Methotrexate—ankylosing spondylitis	0.000128	0.000585	CcSEcCtD
Sunitinib—Nausea—Triamcinolone—ankylosing spondylitis	0.000127	0.000581	CcSEcCtD
Sunitinib—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000127	0.00058	CcSEcCtD
Sunitinib—Nausea—Methylprednisolone—ankylosing spondylitis	0.000127	0.00058	CcSEcCtD
Sunitinib—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000126	0.000576	CcSEcCtD
Sunitinib—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000125	0.00057	CcSEcCtD
Sunitinib—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000124	0.000569	CcSEcCtD
Sunitinib—Vomiting—Betamethasone—ankylosing spondylitis	0.000124	0.000565	CcSEcCtD
Sunitinib—Vomiting—Dexamethasone—ankylosing spondylitis	0.000124	0.000565	CcSEcCtD
Sunitinib—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000123	0.000562	CcSEcCtD
Sunitinib—Rash—Betamethasone—ankylosing spondylitis	0.000122	0.00056	CcSEcCtD
Sunitinib—Rash—Dexamethasone—ankylosing spondylitis	0.000122	0.00056	CcSEcCtD
Sunitinib—Dermatitis—Betamethasone—ankylosing spondylitis	0.000122	0.000559	CcSEcCtD
Sunitinib—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000122	0.000559	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000122	0.000558	CcSEcCtD
Sunitinib—Fatigue—Methotrexate—ankylosing spondylitis	0.000122	0.000557	CcSEcCtD
Sunitinib—Headache—Dexamethasone—ankylosing spondylitis	0.000122	0.000556	CcSEcCtD
Sunitinib—Headache—Betamethasone—ankylosing spondylitis	0.000122	0.000556	CcSEcCtD
Sunitinib—Asthenia—Prednisone—ankylosing spondylitis	0.000121	0.000555	CcSEcCtD
Sunitinib—Pain—Methotrexate—ankylosing spondylitis	0.000121	0.000553	CcSEcCtD
Sunitinib—Pruritus—Prednisone—ankylosing spondylitis	0.00012	0.000547	CcSEcCtD
Sunitinib—Diarrhoea—Prednisone—ankylosing spondylitis	0.000116	0.000529	CcSEcCtD
Sunitinib—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000116	0.000529	CcSEcCtD
Sunitinib—Nausea—Betamethasone—ankylosing spondylitis	0.000115	0.000527	CcSEcCtD
Sunitinib—Nausea—Dexamethasone—ankylosing spondylitis	0.000115	0.000527	CcSEcCtD
Sunitinib—Dizziness—Prednisone—ankylosing spondylitis	0.000112	0.000511	CcSEcCtD
Sunitinib—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000112	0.000511	CcSEcCtD
Sunitinib—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000112	0.000511	CcSEcCtD
Sunitinib—Vomiting—Prednisone—ankylosing spondylitis	0.000108	0.000492	CcSEcCtD
Sunitinib—Rash—Prednisone—ankylosing spondylitis	0.000107	0.000488	CcSEcCtD
Sunitinib—Dermatitis—Prednisone—ankylosing spondylitis	0.000107	0.000487	CcSEcCtD
Sunitinib—Headache—Prednisone—ankylosing spondylitis	0.000106	0.000484	CcSEcCtD
Sunitinib—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000104	0.000476	CcSEcCtD
Sunitinib—Asthenia—Methotrexate—ankylosing spondylitis	0.000101	0.000464	CcSEcCtD
Sunitinib—Nausea—Prednisone—ankylosing spondylitis	0.0001	0.000459	CcSEcCtD
Sunitinib—Pruritus—Methotrexate—ankylosing spondylitis	0.0001	0.000457	CcSEcCtD
Sunitinib—Diarrhoea—Methotrexate—ankylosing spondylitis	9.67e-05	0.000442	CcSEcCtD
Sunitinib—Dizziness—Methotrexate—ankylosing spondylitis	9.35e-05	0.000427	CcSEcCtD
Sunitinib—Vomiting—Methotrexate—ankylosing spondylitis	8.99e-05	0.000411	CcSEcCtD
Sunitinib—Rash—Methotrexate—ankylosing spondylitis	8.92e-05	0.000408	CcSEcCtD
Sunitinib—Dermatitis—Methotrexate—ankylosing spondylitis	8.91e-05	0.000407	CcSEcCtD
Sunitinib—Headache—Methotrexate—ankylosing spondylitis	8.86e-05	0.000405	CcSEcCtD
Sunitinib—Nausea—Methotrexate—ankylosing spondylitis	8.4e-05	0.000384	CcSEcCtD
Sunitinib—TBK1—Immune System—TLR4—ankylosing spondylitis	3.65e-05	0.000137	CbGpPWpGaD
Sunitinib—RPS6KA1—Developmental Biology—TNF—ankylosing spondylitis	3.64e-05	0.000137	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—CRP—ankylosing spondylitis	3.64e-05	0.000137	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—CRP—ankylosing spondylitis	3.64e-05	0.000137	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL1RN—ankylosing spondylitis	3.63e-05	0.000137	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—IL1A—ankylosing spondylitis	3.62e-05	0.000136	CbGpPWpGaD
Sunitinib—MAP2K1—MAPK Signaling Pathway—TNF—ankylosing spondylitis	3.61e-05	0.000136	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—PTGER4—ankylosing spondylitis	3.6e-05	0.000136	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—HLA-B—ankylosing spondylitis	3.6e-05	0.000135	CbGpPWpGaD
Sunitinib—TYK2—Innate Immune System—TLR4—ankylosing spondylitis	3.6e-05	0.000135	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—CD40LG—ankylosing spondylitis	3.6e-05	0.000135	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—MMP3—ankylosing spondylitis	3.59e-05	0.000135	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL1RN—ankylosing spondylitis	3.59e-05	0.000135	CbGpPWpGaD
Sunitinib—CAMK2G—Immune System—TLR4—ankylosing spondylitis	3.58e-05	0.000135	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—HLA-A—ankylosing spondylitis	3.56e-05	0.000134	CbGpPWpGaD
Sunitinib—FGFR2—Innate Immune System—TLR4—ankylosing spondylitis	3.55e-05	0.000134	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	3.55e-05	0.000134	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—CD40LG—ankylosing spondylitis	3.55e-05	0.000133	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HLA-C—ankylosing spondylitis	3.54e-05	0.000133	CbGpPWpGaD
Sunitinib—BLK—Immune System—IL1A—ankylosing spondylitis	3.53e-05	0.000133	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL1RN—ankylosing spondylitis	3.52e-05	0.000133	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL1RN—ankylosing spondylitis	3.52e-05	0.000133	CbGpPWpGaD
Sunitinib—FGR—Immune System—IL1A—ankylosing spondylitis	3.52e-05	0.000132	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—HLA-B—ankylosing spondylitis	3.51e-05	0.000132	CbGpPWpGaD
Sunitinib—BLK—Immune System—CD40LG—ankylosing spondylitis	3.51e-05	0.000132	CbGpPWpGaD
Sunitinib—FGR—Immune System—CD40LG—ankylosing spondylitis	3.5e-05	0.000132	CbGpPWpGaD
Sunitinib—MAP3K3—Immune System—TLR4—ankylosing spondylitis	3.5e-05	0.000132	CbGpPWpGaD
Sunitinib—KIT—Innate Immune System—TLR4—ankylosing spondylitis	3.49e-05	0.000131	CbGpPWpGaD
Sunitinib—MAP3K7—Innate Immune System—TLR4—ankylosing spondylitis	3.49e-05	0.000131	CbGpPWpGaD
Sunitinib—FGFR1—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.48e-05	0.000131	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—PTGER4—ankylosing spondylitis	3.47e-05	0.000131	CbGpPWpGaD
Sunitinib—PDGFRA—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.47e-05	0.000131	CbGpPWpGaD
Sunitinib—YES1—Immune System—CD79A—ankylosing spondylitis	3.46e-05	0.00013	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HLA-C—ankylosing spondylitis	3.46e-05	0.00013	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—HLA-A—ankylosing spondylitis	3.46e-05	0.00013	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—CRP—ankylosing spondylitis	3.45e-05	0.00013	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—CRP—ankylosing spondylitis	3.45e-05	0.00013	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—HLA-A—ankylosing spondylitis	3.43e-05	0.000129	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—HLA-B—ankylosing spondylitis	3.42e-05	0.000129	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—CD40LG—ankylosing spondylitis	3.42e-05	0.000129	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—CRP—ankylosing spondylitis	3.39e-05	0.000128	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—MMP3—ankylosing spondylitis	3.39e-05	0.000127	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—HLA-B—ankylosing spondylitis	3.38e-05	0.000127	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—HLA-B—ankylosing spondylitis	3.37e-05	0.000127	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—PTGER4—ankylosing spondylitis	3.37e-05	0.000127	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—HLA-B—ankylosing spondylitis	3.37e-05	0.000127	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—MMP3—ankylosing spondylitis	3.36e-05	0.000127	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—PTGER4—ankylosing spondylitis	3.34e-05	0.000126	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL1RN—ankylosing spondylitis	3.34e-05	0.000126	CbGpPWpGaD
Sunitinib—BLK—Immune System—HLA-B—ankylosing spondylitis	3.34e-05	0.000126	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL1RN—ankylosing spondylitis	3.33e-05	0.000126	CbGpPWpGaD
Sunitinib—FYN—Immune System—HLA-C—ankylosing spondylitis	3.33e-05	0.000125	CbGpPWpGaD
Sunitinib—FGR—Immune System—HLA-B—ankylosing spondylitis	3.33e-05	0.000125	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—PTGER4—ankylosing spondylitis	3.32e-05	0.000125	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HLA-C—ankylosing spondylitis	3.32e-05	0.000125	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—TLR4—ankylosing spondylitis	3.31e-05	0.000125	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—TLR4—ankylosing spondylitis	3.3e-05	0.000124	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—CRP—ankylosing spondylitis	3.3e-05	0.000124	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CD79A—ankylosing spondylitis	3.28e-05	0.000124	CbGpPWpGaD
Sunitinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	3.26e-05	0.000123	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—TLR4—ankylosing spondylitis	3.25e-05	0.000122	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—HLA-B—ankylosing spondylitis	3.25e-05	0.000122	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—PTGER4—ankylosing spondylitis	3.22e-05	0.000121	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—PTGER4—ankylosing spondylitis	3.22e-05	0.000121	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—PTGER4—ankylosing spondylitis	3.22e-05	0.000121	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—HLA-B—ankylosing spondylitis	3.22e-05	0.000121	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CD79A—ankylosing spondylitis	3.19e-05	0.00012	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—CRP—ankylosing spondylitis	3.18e-05	0.00012	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HLA-C—ankylosing spondylitis	3.17e-05	0.000119	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—HLA-A—ankylosing spondylitis	3.17e-05	0.000119	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—TLR4—ankylosing spondylitis	3.16e-05	0.000119	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CD79A—ankylosing spondylitis	3.15e-05	0.000119	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—PTGER4—ankylosing spondylitis	3.14e-05	0.000118	CbGpPWpGaD
Sunitinib—PDGFRB—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.12e-05	0.000118	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—CRP—ankylosing spondylitis	3.1e-05	0.000117	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CD79A—ankylosing spondylitis	3.09e-05	0.000116	CbGpPWpGaD
Sunitinib—KIT—Immune System—CD79A—ankylosing spondylitis	3.09e-05	0.000116	CbGpPWpGaD
Sunitinib—BLK—Immune System—HLA-A—ankylosing spondylitis	3.09e-05	0.000116	CbGpPWpGaD
Sunitinib—FGR—Immune System—HLA-A—ankylosing spondylitis	3.08e-05	0.000116	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL1RN—ankylosing spondylitis	3.08e-05	0.000116	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—TLR4—ankylosing spondylitis	3.05e-05	0.000115	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—MMP3—ankylosing spondylitis	3.03e-05	0.000114	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—CRP—ankylosing spondylitis	3.02e-05	0.000114	CbGpPWpGaD
Sunitinib—FYN—Adaptive Immune System—HLA-A—ankylosing spondylitis	3.01e-05	0.000113	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL1RN—ankylosing spondylitis	3e-05	0.000113	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—CRP—ankylosing spondylitis	2.99e-05	0.000113	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—TLR4—ankylosing spondylitis	2.98e-05	0.000112	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—CRP—ankylosing spondylitis	2.98e-05	0.000112	CbGpPWpGaD
Sunitinib—BLK—Immune System—CRP—ankylosing spondylitis	2.95e-05	0.000111	CbGpPWpGaD
Sunitinib—FGR—Immune System—CRP—ankylosing spondylitis	2.94e-05	0.000111	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CD79A—ankylosing spondylitis	2.94e-05	0.00011	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CD79A—ankylosing spondylitis	2.93e-05	0.00011	CbGpPWpGaD
Sunitinib—RPS6KA3—Developmental Biology—TNF—ankylosing spondylitis	2.9e-05	0.000109	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MMP3—ankylosing spondylitis	2.9e-05	0.000109	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—TLR4—ankylosing spondylitis	2.9e-05	0.000109	CbGpPWpGaD
Sunitinib—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	2.9e-05	0.000109	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL1RN—ankylosing spondylitis	2.9e-05	0.000109	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL1RN—ankylosing spondylitis	2.88e-05	0.000108	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—TLR4—ankylosing spondylitis	2.87e-05	0.000108	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—TLR4—ankylosing spondylitis	2.85e-05	0.000107	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—CRP—ankylosing spondylitis	2.84e-05	0.000107	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL1A—ankylosing spondylitis	2.84e-05	0.000107	CbGpPWpGaD
Sunitinib—BLK—Immune System—TLR4—ankylosing spondylitis	2.83e-05	0.000106	CbGpPWpGaD
Sunitinib—YES1—Immune System—CD40LG—ankylosing spondylitis	2.82e-05	0.000106	CbGpPWpGaD
Sunitinib—FGR—Immune System—TLR4—ankylosing spondylitis	2.82e-05	0.000106	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—B3GNT2—ankylosing spondylitis	2.82e-05	0.000106	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—B3GNT2—ankylosing spondylitis	2.79e-05	0.000105	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL1RN—ankylosing spondylitis	2.75e-05	0.000104	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—PTGER4—ankylosing spondylitis	2.73e-05	0.000103	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—TLR4—ankylosing spondylitis	2.73e-05	0.000103	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MMP3—ankylosing spondylitis	2.72e-05	0.000103	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD79A—ankylosing spondylitis	2.7e-05	0.000102	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MMP3—ankylosing spondylitis	2.7e-05	0.000102	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL1A—ankylosing spondylitis	2.69e-05	0.000101	CbGpPWpGaD
Sunitinib—YES1—Immune System—HLA-B—ankylosing spondylitis	2.69e-05	0.000101	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CD40LG—ankylosing spondylitis	2.68e-05	0.000101	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD79A—ankylosing spondylitis	2.64e-05	9.93e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL1A—ankylosing spondylitis	2.61e-05	9.84e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CD40LG—ankylosing spondylitis	2.6e-05	9.79e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—PTGER4—ankylosing spondylitis	2.59e-05	9.74e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL1A—ankylosing spondylitis	2.58e-05	9.72e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CD40LG—ankylosing spondylitis	2.57e-05	9.66e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—MMP3—ankylosing spondylitis	2.56e-05	9.66e-05	CbGpPWpGaD
Sunitinib—ROCK1—Developmental Biology—TNF—ankylosing spondylitis	2.56e-05	9.65e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—HLA-B—ankylosing spondylitis	2.55e-05	9.59e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD79A—ankylosing spondylitis	2.54e-05	9.57e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL1A—ankylosing spondylitis	2.54e-05	9.55e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL1A—ankylosing spondylitis	2.54e-05	9.55e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD79A—ankylosing spondylitis	2.53e-05	9.52e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—CD40LG—ankylosing spondylitis	2.52e-05	9.49e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CD40LG—ankylosing spondylitis	2.52e-05	9.49e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—PTGER4—ankylosing spondylitis	2.51e-05	9.45e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—HLA-A—ankylosing spondylitis	2.49e-05	9.37e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—PTGER4—ankylosing spondylitis	2.48e-05	9.33e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—HLA-B—ankylosing spondylitis	2.47e-05	9.31e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MMP3—ankylosing spondylitis	2.47e-05	9.31e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—HLA-B—ankylosing spondylitis	2.44e-05	9.19e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—PTGER4—ankylosing spondylitis	2.44e-05	9.17e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—PTGER4—ankylosing spondylitis	2.44e-05	9.17e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD79A—ankylosing spondylitis	2.42e-05	9.1e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL1A—ankylosing spondylitis	2.41e-05	9.06e-05	CbGpPWpGaD
Sunitinib—KDR—Developmental Biology—TNF—ankylosing spondylitis	2.41e-05	9.06e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL1A—ankylosing spondylitis	2.4e-05	9.04e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—MMP3—ankylosing spondylitis	2.4e-05	9.03e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—HLA-B—ankylosing spondylitis	2.4e-05	9.03e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—HLA-B—ankylosing spondylitis	2.4e-05	9.03e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CD40LG—ankylosing spondylitis	2.39e-05	9.01e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CD40LG—ankylosing spondylitis	2.39e-05	8.98e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MMP3—ankylosing spondylitis	2.38e-05	8.97e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—CRP—ankylosing spondylitis	2.37e-05	8.94e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MMP3—ankylosing spondylitis	2.37e-05	8.91e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—HLA-A—ankylosing spondylitis	2.36e-05	8.88e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—PTGER4—ankylosing spondylitis	2.31e-05	8.7e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—PTGER4—ankylosing spondylitis	2.31e-05	8.68e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MMP3—ankylosing spondylitis	2.29e-05	8.64e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MMP3—ankylosing spondylitis	2.29e-05	8.64e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—MMP3—ankylosing spondylitis	2.29e-05	8.63e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—HLA-A—ankylosing spondylitis	2.29e-05	8.62e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—HLA-B—ankylosing spondylitis	2.28e-05	8.57e-05	CbGpPWpGaD
Sunitinib—YES1—Immune System—TLR4—ankylosing spondylitis	2.28e-05	8.57e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—HLA-B—ankylosing spondylitis	2.27e-05	8.55e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—HLA-A—ankylosing spondylitis	2.26e-05	8.52e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—CRP—ankylosing spondylitis	2.25e-05	8.47e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MMP3—ankylosing spondylitis	2.24e-05	8.42e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—HLA-A—ankylosing spondylitis	2.22e-05	8.36e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—HLA-A—ankylosing spondylitis	2.22e-05	8.36e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL1A—ankylosing spondylitis	2.22e-05	8.34e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD40LG—ankylosing spondylitis	2.2e-05	8.29e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—CRP—ankylosing spondylitis	2.19e-05	8.23e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL1A—ankylosing spondylitis	2.16e-05	8.14e-05	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—TLR4—ankylosing spondylitis	2.16e-05	8.13e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—CRP—ankylosing spondylitis	2.16e-05	8.13e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD40LG—ankylosing spondylitis	2.15e-05	8.09e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—PTGER4—ankylosing spondylitis	2.13e-05	8.01e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—CRP—ankylosing spondylitis	2.12e-05	7.98e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—CRP—ankylosing spondylitis	2.12e-05	7.98e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—HLA-A—ankylosing spondylitis	2.12e-05	7.96e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—HLA-A—ankylosing spondylitis	2.11e-05	7.94e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—HLA-A—ankylosing spondylitis	2.1e-05	7.92e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HLA-B—ankylosing spondylitis	2.1e-05	7.89e-05	CbGpPWpGaD
Sunitinib—TYK2—Immune System—TLR4—ankylosing spondylitis	2.1e-05	7.89e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—HLA-A—ankylosing spondylitis	2.09e-05	7.86e-05	CbGpPWpGaD
Sunitinib—YES1—Developmental Biology—TNF—ankylosing spondylitis	2.09e-05	7.86e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL1A—ankylosing spondylitis	2.08e-05	7.85e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—PTGER4—ankylosing spondylitis	2.08e-05	7.82e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL1A—ankylosing spondylitis	2.07e-05	7.8e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD40LG—ankylosing spondylitis	2.07e-05	7.8e-05	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—TLR4—ankylosing spondylitis	2.07e-05	7.79e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD40LG—ankylosing spondylitis	2.06e-05	7.76e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—HLA-A—ankylosing spondylitis	2.05e-05	7.72e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HLA-B—ankylosing spondylitis	2.05e-05	7.7e-05	CbGpPWpGaD
Sunitinib—KIT—Immune System—TLR4—ankylosing spondylitis	2.03e-05	7.65e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—TLR4—ankylosing spondylitis	2.03e-05	7.65e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	2.02e-05	7.59e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—CRP—ankylosing spondylitis	2.01e-05	7.57e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—CRP—ankylosing spondylitis	2.01e-05	7.55e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—PTGER4—ankylosing spondylitis	2e-05	7.54e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—PTGER4—ankylosing spondylitis	1.99e-05	7.49e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL1A—ankylosing spondylitis	1.98e-05	7.46e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—HLA-B—ankylosing spondylitis	1.97e-05	7.42e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD40LG—ankylosing spondylitis	1.97e-05	7.42e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HLA-B—ankylosing spondylitis	1.96e-05	7.38e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—HLA-A—ankylosing spondylitis	1.95e-05	7.33e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—HLA-A—ankylosing spondylitis	1.94e-05	7.31e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—HLA-A—ankylosing spondylitis	1.94e-05	7.31e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MMP3—ankylosing spondylitis	1.94e-05	7.31e-05	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—TLR4—ankylosing spondylitis	1.93e-05	7.26e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—TLR4—ankylosing spondylitis	1.92e-05	7.24e-05	CbGpPWpGaD
Sunitinib—TYK2—Developmental Biology—TNF—ankylosing spondylitis	1.92e-05	7.24e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—PTGER4—ankylosing spondylitis	1.9e-05	7.16e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—HLA-A—ankylosing spondylitis	1.9e-05	7.13e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HLA-B—ankylosing spondylitis	1.87e-05	7.05e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CRP—ankylosing spondylitis	1.85e-05	6.97e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MMP3—ankylosing spondylitis	1.84e-05	6.93e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—HLA-A—ankylosing spondylitis	1.83e-05	6.88e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—HLA-A—ankylosing spondylitis	1.82e-05	6.84e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CRP—ankylosing spondylitis	1.81e-05	6.81e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—HLA-A—ankylosing spondylitis	1.79e-05	6.75e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MMP3—ankylosing spondylitis	1.79e-05	6.73e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—TLR4—ankylosing spondylitis	1.78e-05	6.69e-05	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—TNF—ankylosing spondylitis	1.77e-05	6.66e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MMP3—ankylosing spondylitis	1.77e-05	6.65e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—HLA-A—ankylosing spondylitis	1.75e-05	6.59e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—CRP—ankylosing spondylitis	1.74e-05	6.56e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—HLA-A—ankylosing spondylitis	1.74e-05	6.54e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MMP3—ankylosing spondylitis	1.73e-05	6.53e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MMP3—ankylosing spondylitis	1.73e-05	6.53e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—TLR4—ankylosing spondylitis	1.73e-05	6.52e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CRP—ankylosing spondylitis	1.73e-05	6.52e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—HLA-A—ankylosing spondylitis	1.69e-05	6.35e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—HLA-A—ankylosing spondylitis	1.68e-05	6.31e-05	CbGpPWpGaD
Sunitinib—FYN—Immune System—TLR4—ankylosing spondylitis	1.67e-05	6.29e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—TLR4—ankylosing spondylitis	1.66e-05	6.26e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CRP—ankylosing spondylitis	1.66e-05	6.24e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MMP3—ankylosing spondylitis	1.65e-05	6.19e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP3—ankylosing spondylitis	1.64e-05	6.18e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—TNF—ankylosing spondylitis	1.63e-05	6.14e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—HLA-A—ankylosing spondylitis	1.6e-05	6.03e-05	CbGpPWpGaD
Sunitinib—JAK2—Immune System—TLR4—ankylosing spondylitis	1.59e-05	5.98e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—TNF—ankylosing spondylitis	1.53e-05	5.77e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—TNF—ankylosing spondylitis	1.53e-05	5.74e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	1.52e-05	5.73e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP3—ankylosing spondylitis	1.52e-05	5.7e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP3—ankylosing spondylitis	1.48e-05	5.57e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—TNF—ankylosing spondylitis	1.46e-05	5.49e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.43e-05	5.38e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP3—ankylosing spondylitis	1.43e-05	5.37e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP3—ankylosing spondylitis	1.42e-05	5.34e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP3—ankylosing spondylitis	1.35e-05	5.1e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—B3GNT2—ankylosing spondylitis	9.38e-06	3.53e-05	CbGpPWpGaD
